K2 Principal Fund’s Aegerion Pharmaceuticals AEGR Stock Holding History

K2 Principal Fund’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-124,454	Closed	-$370K	–	381
2016 Q3	$370K	Sell	124,454 -395,711	-76%	-$686K	0.04%	216
2016 Q2	$775K	Buy	+520,165	New	+$1.19M	0.1%	142

K2 Principal Fund's AEGR Position: Q4 2016 in Review

K2 Principal Fund sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 124,454 shares — an estimated $370K sold.

K2 Principal Fund first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $775K in Q2 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

K2 Principal Fund reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
K2 Principal Fund sold 124,454 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $370K.
K2 Principal Fund first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
K2 Principal Fund's Aegerion Pharmaceuticals position peaked at $775K in Q2 2016.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on K2 Principal Fund's 13F filing for Q4 2016, filed 15 Feb 2017.